JPWO2021067326A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021067326A5
JPWO2021067326A5 JP2022520195A JP2022520195A JPWO2021067326A5 JP WO2021067326 A5 JPWO2021067326 A5 JP WO2021067326A5 JP 2022520195 A JP2022520195 A JP 2022520195A JP 2022520195 A JP2022520195 A JP 2022520195A JP WO2021067326 A5 JPWO2021067326 A5 JP WO2021067326A5
Authority
JP
Japan
Prior art keywords
isopropyl
pyrrolo
triazolo
pyridin
thiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022520195A
Other languages
English (en)
Japanese (ja)
Other versions
JP7629007B2 (ja
JP2022550203A5 (https=
JP2022550203A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/053358 external-priority patent/WO2021067326A1/en
Publication of JP2022550203A publication Critical patent/JP2022550203A/ja
Publication of JP2022550203A5 publication Critical patent/JP2022550203A5/ja
Publication of JPWO2021067326A5 publication Critical patent/JPWO2021067326A5/ja
Application granted granted Critical
Publication of JP7629007B2 publication Critical patent/JP7629007B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022520195A 2019-10-01 2020-09-30 置換二環ヘテロアリール化合物 Active JP7629007B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962908840P 2019-10-01 2019-10-01
US62/908,840 2019-10-01
PCT/US2020/053358 WO2021067326A1 (en) 2019-10-01 2020-09-30 Substituted bicyclic heteroaryl compounds

Publications (4)

Publication Number Publication Date
JP2022550203A JP2022550203A (ja) 2022-11-30
JP2022550203A5 JP2022550203A5 (https=) 2023-09-28
JPWO2021067326A5 true JPWO2021067326A5 (https=) 2023-09-28
JP7629007B2 JP7629007B2 (ja) 2025-02-12

Family

ID=72896115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520195A Active JP7629007B2 (ja) 2019-10-01 2020-09-30 置換二環ヘテロアリール化合物

Country Status (6)

Country Link
US (1) US12448395B2 (https=)
EP (1) EP4041730A1 (https=)
JP (1) JP7629007B2 (https=)
KR (1) KR20220075381A (https=)
CN (1) CN114761404B (https=)
WO (1) WO2021067326A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116783202A (zh) * 2021-02-09 2023-09-19 吉利德科学公司 噻吩并吡咯化合物
PL4291562T3 (pl) * 2021-02-09 2026-02-16 Gilead Sciences, Inc. Związki tienopirolu
CR20230478A (es) 2021-04-16 2023-11-30 Gilead Sciences Inc Compuestos de tienopirrol.
KR20240056747A (ko) * 2021-09-10 2024-04-30 길리애드 사이언시즈, 인코포레이티드 티에노피롤 화합물
WO2026002036A1 (zh) * 2024-06-26 2026-01-02 北京双鹤润创科技有限公司 一种化合物及其用途

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
WO2000035886A2 (en) 1998-12-18 2000-06-22 Axys Pharmaceuticals, Inc. (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
HRP20020349A2 (en) 1999-10-19 2004-02-29 Merck & Co Inc Tyrosine kinase inhibitors
AU2003235741B8 (en) 2002-01-07 2009-01-15 Eisai R&D Management Co., Ltd. Deazapurines and uses thereof
FR2836915B1 (fr) 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
BRPI0411514A (pt) 2003-06-20 2006-08-01 Coley Pharm Gmbh antagonistas de receptor toll-like de molécula pequena
WO2006113458A1 (en) 2005-04-15 2006-10-26 Bristol-Myers Squibb Company Heterocyclic inhibitors of protein arginine methyl transferases
RS50821B (sr) 2005-06-27 2010-08-31 Sanofi-Aventis Derivati pirazolopiridina kao inhibitori beta-adrenergičnog receptora kinaze 1
CA2648652A1 (en) 2006-04-04 2007-10-11 Myriad Genetics, Inc. Compounds for diseases and disorders
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
US8027888B2 (en) 2006-08-31 2011-09-27 Experian Interactive Innovation Center, Llc Online credit card prescreen systems and methods
JP2010511018A (ja) 2006-12-01 2010-04-08 ガラパゴス・ナムローゼ・フェンノートシャップ 変性疾患及び炎症性疾患の治療に有用なトリアゾロピリジン化合物
WO2008152471A1 (en) 2007-06-12 2008-12-18 Coley Pharmaceutical Group, Inc. Quinazoline derivative useful as toll-like receptor antagonist
WO2009030996A1 (en) 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
EP2205085A1 (en) 2007-09-25 2010-07-14 Merck Sharp & Dohme Corp. 2-aryl or heteroaryl indole derivatives
WO2010036905A1 (en) 2008-09-26 2010-04-01 Eisai R & D Management Co., Ltd. Benzoxazole compounds and methods of use
US8785489B2 (en) 2008-10-17 2014-07-22 Boehringer Ingelheim International Gmbh Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
JP5864417B2 (ja) 2009-07-16 2016-02-17 マリンクロッド エルエルシー トール様受容体9のアンタゴニストとしての(+)−モルフィナンおよびその治療的使用
RU2012116207A (ru) 2009-09-24 2013-10-27 Ф.Хоффманн-Ля Рош Аг Производные индола в качестве модуляторов crac
MX2012004792A (es) 2009-10-22 2013-02-01 Vertex Pharma Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas.
DE102009058280A1 (de) 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
WO2012054862A2 (en) 2010-10-21 2012-04-26 The Brigham And Women's Hospital, Inc. Agents, compositions, and methods for treating pruritis and related skin conditions
DK2663550T3 (en) 2011-01-12 2017-03-27 Ventirx Pharmaceuticals Inc SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
CN103562201B (zh) 2011-01-12 2016-10-19 帆德制药股份有限公司 作为toll样受体调节剂的取代的苯并氮杂卓
WO2012167053A1 (en) 2011-06-01 2012-12-06 Janus Biotherapeutics, Inc. Novel immune system modulators
KR102052215B1 (ko) 2011-06-01 2019-12-04 야누스 바이오테라퓨틱스, 인크. 신규한 면역 시스템 조절제
KR101913619B1 (ko) 2011-06-09 2018-12-28 리젠 파마슈티컬스 소시에떼 아노님 Gpr-119의 조절제로서의 신규한 화합물
KR101913135B1 (ko) 2011-07-15 2018-10-30 얀센 파마슈티칼즈, 인코포레이티드 감마 세크레타제 조절 인자로서의 신규의 치환 인돌 유도체
WO2013052550A2 (en) 2011-10-04 2013-04-11 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
TWI619704B (zh) 2012-05-18 2018-04-01 大日本住友製藥股份有限公司 羧酸化合物
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
US9761813B2 (en) 2012-08-10 2017-09-12 Doosan Corporation Organic light-emitting compound and organic electroluminescent device using same
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
JP6223563B2 (ja) 2013-10-14 2017-11-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 選択的に置換されたキノリン化合物
CN105992766A (zh) 2013-12-13 2016-10-05 武田药品工业株式会社 作为tlr抑制剂的吡咯并[3,2-c]吡啶衍生物
HUE054672T2 (hu) 2014-08-15 2021-09-28 Chia Tai Tianqing Pharmaceutical Group Co Ltd TLR7 agonistaként alkalmazott pirrolopirimidin vegyületek
EP3398948A3 (en) 2014-08-22 2018-12-05 Janus Biotherapeutics, Inc. 2,4,6,7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
MX2018014034A (es) 2016-05-25 2019-08-29 Akarna Therapeutics Ltd Compuestos bicíclicos fusionados para el tratamiento de enfermedades.
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BR112019001270A2 (pt) 2016-07-30 2019-04-30 Bristol-Myers Squibb Company compostos indol substituídos com dimetoxifenila como inibidores de tlr7, tlr8 ou tlr9
JP7028861B2 (ja) 2016-09-09 2022-03-02 ブリストル-マイヤーズ スクイブ カンパニー ピリジル置換のインドール化合物
EA202091484A1 (ru) 2017-12-18 2021-03-25 Бристол-Маерс Сквибб Компани 4-азаиндольные соединения
KR102730859B1 (ko) * 2017-12-20 2024-11-15 브리스톨-마이어스 스큅 컴퍼니 아릴 및 헤테로아릴 치환된 인돌 화합물
CN120699039A (zh) * 2019-11-04 2025-09-26 锐新医药公司 Ras抑制剂
MX2022005359A (es) * 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
MX2023002248A (es) * 2020-09-03 2023-05-16 Revolution Medicines Inc Uso de inhibidores de sos1 para tratar neoplasias malignas con mutaciones de shp2.
MX2023003060A (es) * 2020-09-15 2023-04-05 Revolution Medicines Inc Derivados indolicos como inhibidores de ras en el tratamiento del cancer.

Similar Documents

Publication Publication Date Title
JP2021506858A5 (https=)
IL275344B2 (en) 4-azaindole compounds
ES2778700T3 (es) Nuevos derivados de piperidinilo sustituidos con (hetero)arilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
RU2700004C1 (ru) Конденсированные трициклические производные имидазола в качестве модуляторов активности tnf
US7709468B2 (en) Imidazo based heterocycles
RU2473549C2 (ru) Пиримидиновые соединения, композиции и способы применения
ES2485913T3 (es) Compuestos novedosos útiles para el tratamiento de enfermedades degenerativas e inflamatorias
CA2787291C (en) 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
AU2011344001B2 (en) Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
US9637491B2 (en) Pyrazolo[4,3-D]pyrimidines as kinase inhibitors
HRP20200962T1 (hr) Novi spojevi
RU2013120966A (ru) ФУРО[3,2-d]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ
JP2021507912A5 (https=)
JP2021506923A5 (https=)
WO2024229317A1 (en) Spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof
US20060199817A1 (en) Phthalazine, aza- and diaza-phthalazine compounds and methods of use
JP2019535664A5 (https=)
GB2609879A (en) Antagonists of the adenosine A2a receptor
JP2016523911A5 (https=)
KR20130021384A (ko) 신규한 nk-3 수용체 선택적 길항제 화합물, nk-3 수용체 매개형 질환에 사용되기 위한 의약 조성물 및 방법
JP2014506929A5 (https=)
JP2019535689A5 (https=)
HRP20150347T1 (hr) Analozi 2-aminopiridina kao aktivatori glukokinaze
US20260015358A1 (en) Bicyclic derivatives, compositions and uses thereof
JP2016525092A5 (https=)